These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 12792731

  • 1. Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.
    Kurosumi M, Tabei T, Inoue K, Takei H, Ninomiya J, Naganuma R, Suemasu K, Higashi Y, Tsuchiya E.
    Oncol Rep; 2003; 10(4):833-7. PubMed ID: 12792731
    [Abstract] [Full Text] [Related]

  • 2. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M.
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [Abstract] [Full Text] [Related]

  • 3. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
    Jang KS, Han HX, Paik SS, Brown PH, Kong G.
    Cancer Lett; 2006 Dec 08; 244(2):203-10. PubMed ID: 16469432
    [Abstract] [Full Text] [Related]

  • 4. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Dec 08; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M, O'Hanlon DM, Kiely MJ, Connolly Y, Jeffers M, Keane FB.
    Int J Oncol; 2002 Apr 08; 20(4):717-21. PubMed ID: 11894115
    [Abstract] [Full Text] [Related]

  • 6. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 08; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of c-erbB-2 expression in invasive ductal carcinoma of the breast.
    Horiguchi J, Iino Y, Takei H, Morishita Y.
    Jpn J Clin Oncol; 1995 Aug 08; 25(4):119-23. PubMed ID: 7666587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases.
    Buijs JT, Cleton AM, Smit VT, Löwik CW, E Papapoulos S, Pluijm Gv.
    Breast Cancer Res Treat; 2004 Mar 08; 84(2):117-30. PubMed ID: 14999142
    [Abstract] [Full Text] [Related]

  • 10. Expression of proliferating cell nuclear antigen in invasive ductal carcinoma of the breast.
    Horiguchi J, Iino Y, Takei H, Morishita Y, Nakajima T.
    Jpn J Clin Oncol; 1994 Apr 08; 24(2):79-84. PubMed ID: 7908995
    [Abstract] [Full Text] [Related]

  • 11. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 12. Contrast-enhanced dynamic MR imaging parameters and histological types of invasive ductal carcinoma of breast.
    Takeda Y, Yoshikawa K.
    Biomed Pharmacother; 2005 Apr 01; 59(3):115-21. PubMed ID: 15795104
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study.
    Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A.
    Mod Pathol; 2002 May 01; 15(5):502-16. PubMed ID: 12011255
    [Abstract] [Full Text] [Related]

  • 14. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA, Baak JP, Guervós MA, van Diest PJ, Jiwa M, Hermsen MA.
    J Pathol; 2003 Dec 01; 201(4):555-61. PubMed ID: 14648658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF, Patrick RJ, Rybicki LA, Hicks D, Weng DE, Crowe JP.
    Ann Surg Oncol; 2006 Jun 01; 13(6):783-7. PubMed ID: 16604475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ.
    Eur J Surg Oncol; 2006 Jun 01; 32(5):502-6. PubMed ID: 16569492
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J, Tan PH, Thiyagarajan J, Bay BH.
    Mod Pathol; 2003 Jun 01; 16(6):558-65. PubMed ID: 12808061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.